Purpose: The goal of this study is to show the efficacy and safety of an innovative surgical procedure regarding the treatment of openangle and juvenile glaucoma known as sclerothalamotomy ab interno (STT ab interno).
T rabeculectomy, first described in the 1960s, [1] [2] [3] is most likely the surgical procedure of choice for treating glaucoma. The original intention of trabeculectomy was to bypass the resistance of the trabecular meshwork by channeling the aqueous humor directly into the Schlemm canal. It soon became evident that successful reduction of the intraocular pressure (IOP) after trabeculectomy was clearly related to the presence of the subconjunctival filtering bleb. 4 Despite the initial success, a progressive failure rate regarding this treatment derived in most cases by a subconjunctival fibrosis in the filtering bleb was found later. Later on trabeculectomy was found to be associated with serious vision-threatening complications such as postoperative choroidal effusions and hemorrhage, delayed bleb leaks, and bleb-related infections including endophthalmitis as well. These complications are seen more frequently if antimetabolite agents such as 5-fluorouracil and mitomycin C are used.
Initially, the concept of the trabecular meshwork bypass as a surgical principle for the treatment of glaucoma evolved through the innovation that the pathologic outflow resistance is caused primarily by the juxtacanicular trabecular meshwork and, in particular, by the inner wall of the Schlemm canal. 5, 6 Further studies indicated that 35% of the outflow resistance arises distally from the inner wall of the Schlemm canal. 7 The more recent methods of nonpenetrating deep sclerctomy and viscocanalostomy, first described by Fjodorov et al 8 and Stegmann et al, 9 respectively, attempted to improve the uveoscleral outflow and were therefore not considered dependent on the presence of a filtering bleb. In 1976, Benedikt and Hiti 10 first described a surgical technique for glaucoma in which the ciliary body was exposed (ie, a form of penetrating sclerectomy) in which he reported a successfully long-term IOP regulation in 27 of 38 cases (63.2%) involving hemorrhagic, aphakic, and irreversible angle-closure glaucoma after initially failed filtering surgery. This technique was the cornerstone for the later development of the perforating deep sclerectomy as described in that study and since 1985 is termed as ''sclerothalamectomy.'' 11 Later, Spiegel et al 12 described a new surgical technique involving the use of an implanted tube, the trabecular meshwork bypass shunt, which should provide a direct connection between the Schlemm canal and the anterior chamber. This surgical technique avoids any known surgical difficulties of the nonpenetrating procedures.
In conclusion, the sclerothalamotomy ab interno procedure whose initial results are already published in an earlier study, evolved from the later sclerothalmectomy. The results of a 24-month follow-up since the creation of deep sclerotomy ab interno show sufficient decrease of IOP with complete success rate of 90.6% and a low rate of postoperative complications. 13 The aim of this study is to present the 6-year outcomes of this innovative trabecular surgery.
MATERIALS AND METHODS
The main inclusion criterion for this study was an insufficient response to the medical treatment of IOP. Data were documented according to a prospective study protocol. Fifty-three sclerothalamotomies ab interno in 53  patients with open-angle glaucoma and 5 with juvenile glaucoma were carried out between February 1, 2002 and  July 31, 2002. A complete ophthalmologic examination was carried out in each patient before surgery including uncorrected and best corrected visual acuity (VA), IOP applanation tonometry, biomicroscopy of anterior segment, fundoscopy or examination of the fundus (in particular, stereoscopic evaluation of the optic nerve head), and computerized visual field testing (Octopus 101, program G2). For example, hyphema, hypotony, IOP elevation, inflammation, corneal changes, and cataract development were examined for early and late side effects.
A complete ophthalmologic follow-up examination was carried out postoperatively every day (first to the fourth day), at the end of the first, second, and fourth week, and at a regular examination at the end of every month, and every 3 months after the first trimester (1st, 2nd, 3rd, 6th until the 72nd month).
High-frequency Diathermic Probe
The high-frequency diathermic probe (Oertli, Switzerland) consists of an inner platinum electrode, which is isolated from the outer coaxial electrode. The platinum probe tip is 1 mm in length, 0.3 mm high, and 0.6 mm in width and is bent posteriorly at an angle of 15 degrees (Figs. 1A, B) . The external diameter of the probe measures 0.9 mm. The modulated 500 kHz current generates a temperature of approximately 1301C at the tip of the probe. The setup provides high-frequency power dissipation in close vicinity of the tip. As a result, collateral or local heating of the tissue is very limited as it is applied as a rotational ellipsoid.
Surgical Procedure
A clear cornea incision (1.2-mm wide) was made in the temporal upper quadrant using a diamond knife. A second corneal incision was made 120 degrees apart from the first followed by injection of Healon GV. The high-frequency diathermic probe was inserted through the temporal corneal insertion. Visual inspection of the target zone (opposite iridocorneal angle) was done by a 4-mirror gonioscopic lens. The high-frequency tip penetrated up to 1 mm nasally into the sclera through the trabecular meshwork and Schlemm canal, forming a deep sclerotomy (ie, ''thalami'') of 0.3 mm height and 0.6 mm width (Figs. 2, 3 ). This procedure was repeated 4 times within 1 quadrant. Healon GV was evacuated from the anterior chamber with bimanual irrigation/aspiration. Tobramycin/dexamethasone eye drops were then applied 3 times daily for 1 month and pilocarpin 2% eye drops 3 times daily for 10 days.
Evaluation of the Results
Statistical evaluation of the results was done with the SPSS Program Version 14. Two-tailed Student's t test was used for the statistical evaluation of the parametric data. The unit of significance was set at a critical P value of <0.05, including Bonferroni correlation for repetitive use of data sets.
RESULTS
The mean age of patients with open-angle glaucoma was 72.3±12.3 years (range: 15-92 y). Seventeen patients (32%) were female, whereas the rest (68%) were male. The mean age of patients with juvenile glaucoma was 9±1.4 years (range: 7-11 y). Four patients (80%) were male and 1 patient (20%) was a female. In 25 cases (47.4%), the right eye was treated and in 28 cases (52.6%) the left eye was treated. With regard to the open-angle glaucoma group, while in the juvenile group was treated in 3 cases (60%) in the right eye, in 2 cases (40%) the left eye was treated. (Figs. 4, 5) . The IOP reduction at any time of standardized follow-up was statistically significant compared with the preoperative data at a level of a<0.03 (Bonferroni corrected). However, because of only a few cases in the juvenile glaucoma group conclusive statistics were not available, although the results showed the decreasing tendency of IOP.
At the 72nd month, 52.8% of patients with open-angle glaucoma showed an IOP less than 15 mm Hg, 76% showed an IOP less than 18 mm Hg, and 79.2% showed an IOP less than 21 mm Hg (Fig. 6 ). Eighty percent of the patients with juvenile glaucoma showed an IOP less than 15 mm Hg, whereas 100% of the patients in this group showed an IOP less than 18 mm Hg. In the open-angle glaucoma group after 72 months, 84.9% of the patients that were treated achieved more than 20% reduction of IOP whereas a decrease of more than 30% was achieved in 77% of the patients. In the juvenile glaucoma group, a more than 30% decrease of IOP was achieved from all patients.
The IOP values for each of the 53 individual openangle glaucoma patients before and after 72 months of surgery are shown in Figure 7 . The complete success rate, defined as an IOP lower than 21 mm Hg without medication at 72 months, was achieved in 42 patients (79.2%) of the open-angle glaucoma group (Fig. 7) and in 4 patients (80%) of the juvenile glaucoma group. Qualified success rate, defined as an IOP lower than 21 mm Hg, was achieved in all the remaining patients.
All patients were preoperatively under ocular hypotensive agents. The mean number of preoperative ocular hypotensive agents administered per patient was 2.6±1.0 for the open-angle glaucoma group and 3.0±0.0 for the juvenile glaucoma group. After surgery, this value decreased to 0.45±0.72 after 1 month, 0.38±0.60 after 3 months, 0.38±0.69 after 6 months, 0.19±0.52 after 12 months, 0.21±0.53 after 24 months, 0.50±0.90 after 36 months, 0.49±0.96 after 48 months, 0.49±0.93 after 60 months, and 0.51±0.97 after 72 months for the openangle glaucoma group (Fig. 8) . The values with regard to Some early and late postoperative complications were noted in the larger group who underwent this procedure (Table 1) . A hyphema that spontaneously resolved within 2 weeks was observed in 6 eyes (11.4%). Within the first postoperative 24 hours, 1 eye had some anterior chamber fibrin that was treated with topical dexamethasone. One eye (1.9%) had transient ocular hypotension that lasted 3 days. Temporary postoperative ocular hypertension was observed in 12 eyes (22.6%). IOP increase always occurred within the first 6 weeks after the procedure and responded well to less than a 3-week-long ocular hypotensive treatment. Late postoperative complications observed were the development of a cataract with a decrease of 1 Snellen line in VA in 3 (5.7%) eyes and with no decrease in VA in 6 (11.3%) others. Although the authors never experienced such intraoperative complications, sclera perforation from the iridocorneal angle into the subconjunctival space, and direct injury to the lens, iris, or cornea by the diathermic probe could potentially occur.
DISCUSSION
This study reports the long-term results of a new surgical technique for treating open-angle glaucoma and juvenile glaucoma. The STT ab interno method intends the creation of a direct channel between the anterior chamber and the Schlemm canal. Persistence of the sclerotomy can be investigated with a 3-mirror goniolens that typically shows a small cavity in the sclera at the level of the trabecular meshwork, a cavity that tends to remain open over time (Fig. 9) . The STT ab interno tip creates a deep sclerotomy with subsequent access of the aqueous to the scleral layer. Both aspects may facilitate a bypass effect of aqueous outflow. Despite the fact that approximately 85% of the aqueous humor drains (in physiologic terms) transtrabecularly, we artificially created an additional route for the aqueous humor drainage in the case of elevated IOP. There is evidence in the literature that such bypass effects may be present after surgical intervention, which do not lead to the formation of filtering blebs. In an earlier study, 11 it was ascertained that eyes without filter bleb exhibited very stable long-term IOP regulation postoperatively. In addition to the bypassing of trabecular outflow resistance caused by STT ab interno treatment, outflow resistance may be further reduced by scleral thinning at the base of the thalamus. In addition to that, aqueous humor could perhaps be drained to the ciliary body. 11, 14 After early postoperative reduction, the average IOP continued to decrease gradually over a period of 6 months. The IOP remains relatively stable after 6 months postoperatively. It can be speculated that the newly formed blood vessel and lymph vessel close to the surgical site may contribute to the decrease in the IOP level during follow-up. 10 As stated in the literature the success rate for trabeculectomy ranges between 57% and 96%; 15, 19, 29, [31] [32] [33] Comparing the results we find a complete success rate, defined as an IOP lower than 21 mm Hg without medication, the decrease from 90.6% at the 24th month to 79.2% after the 72nd month in the group of open-angle glaucoma. We regard as qualified success the decrease in IOP less than 21 mm Hg with agent administration but with a 100% stability of the IOP target (<21 mm Hg) for the time interval between the 24th month and until the 72nd month or better.
Preliminary histologic investigations of 2 postmortem human eyes after STT ab interno did not indicate signs of indirect necrosis, as, for example, protein denaturation, enlarged or condensed cells, in cell layers adjacent to the thalamus formed by high-frequency diathermy. It is yet unknown whether the inner surface of the thalamus will be covered by endothelial cells of corneal or trabecular origin, and whether the thalamus and its function will remain intact on a much longer time scale. In addition, in vitro experiments performed in porcine enucleated eyes suggested that the aqueous outflow facility increases with the increasing number of deep sclerectomies ab interno (thalamis). Further experiments conducted after perfusing the anterior chamber in enucleated porcine eyes with a drill blue suggests an increase in the uveoscleral outflow pathway after deep sclerectomies ab interno. 34 Some qualities of this method are the comparative simplicity and quickness of the surgical procedure. In addition, the procedure avoids stimulation of episcleral and conjunctival tissues as in trabeculectomy and conventional nonpenetrating surgery.
In this study, diathermy was used to create 4 thalami and this corresponds to a drainage surface area of 2.4 mm 2 . The number of thalami chosen was arbitrary and seems to provide a sufficient long-term decrease in IOP as a low rate of postoperative complications. There is a potential for a further IOP decrease if 6 applications are made and we are currently investigating that. We are also planning a randomized multicenter study to compare STT ab interno, trabeculectomy, and deep sclerectomy for the surgical treatment of open-angle glaucoma.
With regard to the treatment of these 5 cases diagnosed with juvenile glaucoma, the results are encouraging. Sadly, this number of cases is not enough to get conclusive statistics and the results show only a promising tendency. More studies with a higher number of cases are necessary to indicate a significant result interpretation for juvenile glaucoma.
